Picture of Biodexa Pharmaceuticals logo

BDRX — Biodexa Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Biodexa Pharmaceuticals Provides Preliminary Results For Year 2023

April 19 (Reuters) - Biodexa Pharmaceuticals PLC
 5MPy.F :
    * PRELIMINARY RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
    * BIODEXA PHARMACEUTICALS PLC - GROUP'S CONSOLIDATED
FINANCIAL
STATEMENTS HAVE BEEN PRESENTED ON A GOING CONCERN BASIS
    * BIODEXA PHARMACEUTICALS PLC - CONSIDER IT IS APPROPRIATE
TO
CONTINUE TO ADOPT GOING CONCERN BASIS IN PREPARING FINANCIAL
STATEMENTS
    * BIODEXA PHARMACEUTICALS PLC - HAVE RESOURCES TO DELIVER
TWO SETS
OF PRECLINICAL DATA AND THREE SETS OF CLINICAL DATA IN 2024

Source text for Eikon:  ID:nGNXbkfHg8 
Further company coverage:  5MPy.F

Recent news on Biodexa Pharmaceuticals

See all news